Abbott Laboratories said on Wednesday it won U.S. marketing authorization for a Covid-19 portable antigen test that can deliver results within 15 minutes and will sell for $5. CNBC's "Squawk on the Street" crew discusses. Subscribe to CNBC PRO for access to investor and analyst insights: https://cnb.cx/2Vtntx6 The new rapid test for Covid-19 from Abbott Laboratories could be the development that sparks a turnaround for the travel industry, CNBC’s Jim Cramer said Thursday. The medical device company announced on Wednesday night that it received an emergency use authorization from the Food and Drug Administration for a new 15-minute test. Abbott’s stock surged on Thursday morning as some Wall Street analysts called the test a “game changer.” Cramer said on “Squawk on the Street” that, if not for Fed Chair Jerome Powell’s speech, the test would be the biggest markets story of the day. » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC For info on the best credit cards go to CNBC Select: https://www.cnbc.com/select/best-credit-cards/ #CNBC #CNBCTV